Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)

NCT07174713 is registered in ClinicalTrials.gov with Western University, Canada as lead sponsor.

NCT NCT07174713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)
Lead sponsor
Western University, Canada
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 31, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma; eosinophilic